EIP Pharma
Latest round
- Series B
Last raised
- Apr 2018
Total raised
- $21M
Investors
- 1
About EIP Pharma
Founded in 2010 and based in Massachusetts, US, EIP Pharma, Inc. operates as a biotechnology company that develops therapeutic solutions to treat Alzheimer’s disease and other CNS disorders. The company offers Neflamapimod, a brain-penetrant, small-molecule oral inhibitor of p38 alpha for the treatment of Alzheimer's disease.
Who invested in EIP Pharma
1 investor across 1 round
See all investors in EIP Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 13, 2018
Amount
$21M
Investors
Questions about EIP Pharma
Who invested in EIP Pharma?
EIP Pharma has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EIP Pharma raised?
EIP Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EIP Pharma last raise money?
EIP Pharma's most recent round on record is a Series B, in Apr 2018.
What does EIP Pharma do?
Founded in 2010 and based in Massachusetts, US, EIP Pharma, Inc.
Where is EIP Pharma headquartered?
EIP Pharma is headquartered in Boston, US.
Which VCs invest in companies like EIP Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at EIP Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like EIP Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.